Matevž Kmet, PhD, Acies Bio
Matevž Kmet started as a researcher in organic synthesis in Lek Pharmaceuticals. In Lek, he also worked in regulatory affairs and sales (Japan, South Korea, USA, and Canada). He was head of business development in Vitiva (a startup company manufacturing natural antioxidants), Pliva Pharmaceuticals (Croatia), Bosnalijek Pharmaceuticals (Bosnia), and Unafarm (Slovenia). In Teva Pharmaceuticals, he was the head of in-licensing for the EMEA region. Currently, Matevž is working as the head of business development in Acies Bio, a successful, highly innovative Slovenian-based biotech company.